InMode Overview
- Year Founded
-
2008
- Status
-
Public
- Employees
-
581
- Stock Symbol
-
INMD
- Investments
-
1
- Share Price
-
$15.10
- (As of Monday Closing)
InMode General Information
Description
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
Contact Information
Website
www.inmodemd.comCorporate Office
- Tavor Building, Shaar Yokneam
- P.O. Box 533
- Yokneam 2069200
- Israel
Corporate Office
- Tavor Building, Shaar Yokneam
- P.O. Box 533
- Yokneam 2069200
- Israel
InMode Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $15.10 | $15.78 | $15.02 - $29.29 | $1.15B | 76.2M | 1.22M | $1.78 |
InMode Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 779,125 | 1,178,806 | 2,483,265 | 5,007,156 |
| Revenue | 416,626 | 492,048 | 454,271 | 357,565 |
| EBITDA | 134,653 | 196,283 | 198,534 | 167,994 |
| Net Income | 149,199 | 197,919 | 161,520 | 164,971 |
| Total Assets | 859,836 | 863,286 | 644,409 | 478,541 |
| Total Debt | 5,671 | 9,017 | 4,962 | 4,516 |
InMode Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
InMode Comparisons
Industry
Financing
Details
InMode Competitors (9)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cutera | Formerly VC-backed | Brisbane, CA | ||||
| Alma Lasers | Corporation | Nurnberg, Germany | ||||
| Candela Medical | Private Equity-Backed | Marlborough, MA | ||||
| Atricure | Formerly VC-backed | Mason, OH | ||||
| Cynosure (Other Devices and Supplies) | Private Equity-Backed | Westford, MA |
InMode Patents
InMode Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240149058-A1 | Method for treatment of erectile dysfunction | Pending | 03-Nov-2022 | ||
| US-11626276-B1 | Reflector for intense pulse light device | Active | 08-Mar-2022 | ||
| US-20220296910-A1 | Method for treatment of erectile dysfunction | Active | 22-Mar-2021 | ||
| US-12076575-B2 | Method for treatment of erectile dysfunction | Active | 22-Mar-2021 | ||
| US-20220023140-A1 | Device for treatment erectile dysfunction | Pending | 26-Jul-2020 | A61N5/0625 |
InMode Executive Team (12)
| Name | Title | Board Seat |
|---|---|---|
| Moshe Mizrahy | Co-Founder, Chief Executive Officer & Chairman | |
| Yair Malca | Chief Financial Officer, Finance | |
| Michael Kreindel Ph.D | Chief Technology Officer, Technology & Founder | |
| Neil Wolfenden | Managing Director at InMode UK | |
| Nava Tal-Launer | Chief Information Officer |
InMode Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Hadar Ron MD | Self | Board Member | |
| Michael Anghel Ph.D | Self | Board Member | |
| Moshe Mizrahy | InMode | Co-Founder, Chief Executive Officer & Chairman |
InMode Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
InMode Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Viveve Medical (Intellectual Property Assets) | 25-Jul-2023 | Buildings and Property |
InMode ESG
Risk Overview
Risk Rating
Updated May, 17, 2024
28.58 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 16,009
Rank
Percentile
Healthcare
Industry
of 634
Rank
Percentile
Medical Devices
Subindustry
of 225
Rank
Percentile
InMode FAQs
-
When was InMode founded?
InMode was founded in 2008.
-
Who is the founder of InMode?
Moshe Mizrahy and Michael Kreindel Ph.D are the founders of InMode.
-
Who is the CEO of InMode?
Moshe Mizrahy is the CEO of InMode.
-
Where is InMode headquartered?
InMode is headquartered in Yokneam, Israel.
-
What is the size of InMode?
InMode has 581 total employees.
-
What industry is InMode in?
InMode’s primary industry is Other Devices and Supplies.
-
Is InMode a private or public company?
InMode is a Public company.
-
What is InMode’s stock symbol?
The ticker symbol for InMode is INMD.
-
What is the current stock price of InMode?
As of 07-Oct-2024 the stock price of InMode is $15.10.
-
What is the current market cap of InMode?
The current market capitalization of InMode is $1.15B.
-
What is InMode’s current revenue?
The trailing twelve month revenue for InMode is $417M.
-
Who are InMode’s competitors?
Cutera, Alma Lasers, Candela Medical, Atricure, and Cynosure (Other Devices and Supplies) are some of the 9 competitors of InMode.
-
What is InMode’s annual earnings per share (EPS)?
InMode’s EPS for 12 months was $1.78.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
